Electromed Inc.

Electromed Inc.

ELMD

Get informed when a big investor buys or sells

+ Follow
Market Cap$320.27M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Electromed Inc.Electromed Inc.31.7-21%4.9-
$86.95

Current Fair Value

122.3% upside

Undervalued by 122.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$320.27 Million
Enterprise Value$303.29 Million
Dividend Yield$- (-)
Earnings per Share$0.9
Beta0.52
Outstanding Shares8,211,220

Return

Return on Equity20.55%ROE
Return on Assets16.99%
Return on Invested Capital26.86%

Valuation & Multiples

P/E Ratio31.7P/E Ratio
PEG53.92PEG
Price to Sales4.89Price to Sales
Price to Book Ratio7.82Price to Book Ratio
Enterprise Value to Revenue4.23
Enterprise Value to EBIT22.92
Enterprise Value to Net Income30
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
May 12, 2026
EPS Estimate
$0.26
Average shareholder expectation
Revenue Estimate
$17.60 M
Average shareholder expectation

Next Earnings Call

Expected Date
August 25, 2026
EPS Estimate
$0.32
Average shareholder expectation
Revenue Estimate
$19.33 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls20,500 30.03%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %53.56% 0.79%
Total Invested$103.73M 20.68%
Investors Holding1030%

ESG Score

No data

About Electromed Inc.

120 employees

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, Minnesota and was founded in 1992.